Latest filing published 29 May 2026 for Edesa Biotech, Inc..
No signal scores available.
All filings by Peter J. Weiler on record concern Edesa Biotech, Inc. Between 29 May 2025 and 27 May 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 29 May 2026: a share grant, in Edesa Biotech, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations